Business Standard

Thursday, January 23, 2025 | 11:55 AM ISTEN Hindi

Notification Icon
userprofile IconSearch

Biocon Stocks

Ajit Mishra of Religare Broking picks Biocon, Marico as stocks to buy today

Stocks to Buy Today: Ajit Mishra of Religare Broking suggests buying Biocon shares and Marico shares. He also suggests shorting Asian Paints shares

Ajit Mishra of Religare Broking picks Biocon, Marico as stocks to buy today
Updated On : 16 Jan 2025 | 6:34 AM IST

Biocon extends rally, up 6% in 2 days on HSBC, Motilal Oswal 'Buy' upgrade

Notably, Biocon share price has surged about 6 per cent in the last two sessions

Biocon extends rally, up 6% in 2 days on HSBC, Motilal Oswal 'Buy' upgrade
Updated On : 14 Jan 2025 | 10:52 AM IST

Biocon share rises 4% as arm gets Japan's PMDA approval for Psoriasis drug

The rise in Biocon stock was also fuelled after Jefferies upgraded the stock to 'Buy', and raised the target to Rs 400

Biocon share rises 4% as arm gets Japan's PMDA approval for Psoriasis drug
Updated On : 07 Jan 2025 | 9:53 AM IST

Biocon share falls 4% after USFDA issues VAI tag for Bengaluru's API unit

Biocon's Bengaluru API facility was inspected between September 23 to September 27, 2024

Biocon share falls 4% after USFDA issues VAI tag for Bengaluru's API unit
Updated On : 09 Dec 2024 | 10:38 AM IST

Bioengineering is really the way we have to move forward: Mazumdar-Shaw

Says today, we are at an inflection point when it comes to technology. Up until now, we used to scratch at the surface because we couldn't really understand the mysteries of biology

Bioengineering is really the way we have to move forward: Mazumdar-Shaw
Updated On : 19 Nov 2024 | 8:57 PM IST

Biocon Q2 results: Net loss of Rs 16 cr on high tax, revenue at Rs 3,590 cr

Biocon Ltd on Wednesday reported a consolidated net loss of Rs 16 crore for the second quarter ended September 30, 2024 on account of higher tax, based on geographical split of profits. The company had posted a net profit of Rs 126 crore for the July-September period last fiscal. Revenue from operations stood at Rs 3,590 crore in the September quarter as compared with Rs 3,462 crore in the year-ago period, Biocon Ltd said in a statement. "Biocon Group's overall Q2FY25 financial and operational performance provides a foundation for improved performance as we move into the second half of the fiscal," Biocon Group Chairperson Kiran Mazumdar-Shaw said. The group had a robust performance in the biosimilars business driven by strong market share gains in US Oncology and Insulin franchises, she noted. Syngene has returned to sequential growth and has good visibility of a pickup in momentum in the coming quarters led by its discovery services and biomanufacturing CMO business, she ...

Biocon Q2 results: Net loss of Rs 16 cr on high tax, revenue at Rs 3,590 cr
Updated On : 30 Oct 2024 | 7:33 PM IST

Stocks To Watch: SBI, Vedanta, HDFC Bank, Piramal Pharma, Bank of India

Stocks to watch: Piramal Pharma aims to double its revenue to $2 billion by FY30, while tripling its Ebitda, said company Chairperson Nandini Piramal.

Stocks To Watch: SBI, Vedanta, HDFC Bank, Piramal Pharma, Bank of India
Updated On : 26 Sep 2024 | 7:40 AM IST

Stocks to Watch, May 22: Apollo Tyres, Biocon, Gulf Oil, Ircon Int'l

European markets closed on a negative note, with Germany's DAX falling 0.22 per cent and the UK's FTSE dropping 0.09 per cent

Stocks to Watch, May 22: Apollo Tyres, Biocon, Gulf Oil, Ircon Int'l
Updated On : 22 May 2024 | 8:09 AM IST

Eris to buy derma, nephro units of Biocon Biologics for Rs 366 cr

The business includes over 20 mother brands with revenue of Rs 90 crore in FY23 and the current run-rate is around Rs 100 crore

Eris to buy derma, nephro units of Biocon Biologics for Rs 366 cr
Updated On : 08 Nov 2023 | 8:02 PM IST

Biocon slips 4% after USFDA asks for corrective measures at Malaysian unit

The USFDA has determined the inspection classification as 'OAI' (Official Action Indicated) post inspection of Biocon's step-down subsidiary in Malaysia.

Biocon slips 4% after USFDA asks for corrective measures at Malaysian unit
Updated On : 18 Oct 2023 | 10:35 AM IST

Stocks to Watch: RIL, ICICI Bank, Paytm, IGL, Biocon, YES Bank, Cyient DLM

Stocks to Watch on July 24, 2023: Tata Steel, HDFC AMC, Canara Bank, IDBI Bank, TVS Motor will announce their Q1 results today

Stocks to Watch: RIL, ICICI Bank, Paytm, IGL, Biocon, YES Bank, Cyient DLM
Updated On : 24 Jul 2023 | 8:09 AM IST

Biocon beefs up biosimilar portfolio with $3.3-bn Viatris deal, shares fall

The company in a statement said that its subsidiary Biocon Biologics has inked a pact to acquire Viatris Inc's biosimilars business for consideration of up to USD 3.335 billion

Biocon beefs up biosimilar portfolio with $3.3-bn Viatris deal, shares fall
Updated On : 28 Feb 2022 | 6:37 PM IST

Q4 a minor blip in Biocon's growth story, recovery expected in Q1FY21

Analysts estimate 38 per cent annual growth in earnings during FY20-22

Q4 a minor blip in Biocon's growth story, recovery expected in Q1FY21
Updated On : 22 May 2020 | 1:37 AM IST

Biosimilar progress adds to Biocon's prospects as stock gains 14%

Regulatory tailwinds and launches in EU, US to drive earnings

Biosimilar progress adds to Biocon's prospects as stock gains 14%
Updated On : 17 Feb 2018 | 5:55 AM IST